Abbott launches medical device to treat congenital heart defects in premature infants

16 Jun 2021 Evaluate

Abbott has launched a medical device in India which can be implanted in premature infants and newborns who suffer from congenital heart defects. The company has launched Amplatzer Piccolo Occluder in India. This medical device can be implanted in the tiniest babies (weighing as little as 700 grams) using a minimally-invasive procedure to treat conditions like Patent Ductus Arteriosus (PDA).

Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services.

Abbott India Share Price

27776.95 -122.70 (-0.44%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×